{"data":{"id":"us/10-cfr-35.15","jurisdiction":"us","citation":"10 CFR 35.15","heading":"Exemptions regarding Type A specific licenses of broad scope.","body":"A licensee possessing a Type A specific license of broad scope for medical use, issued under Part 33 of this chapter, is exempt from—\n(a) The provisions of § 35.12(d) regarding the need to file an amendment to the license for medical use of byproduct material, as described in § 35.1000;\n(b) The provisions of § 35.13(b);\n(c) The provisions of § 35.13(f) regarding additions to or changes in the areas of use at the addresses identified in the application or on the license;\n(d) The provisions of § 35.14(a);\n(e) The provisions of § 35.14(b)(1) for an authorized user, an authorized nuclear pharmacist, an authorized medical physicist, or an ophthalmic physicist;\n(f) The provisions of § 35.14(b)(5).\n(g) The provisions of § 35.49(a).","path":["Title 10—Energy","CHAPTER I—NUCLEAR REGULATORY COMMISSION","PART 35—MEDICAL USE OF BYPRODUCT MATERIAL","Subpart A—General Information"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-10.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:09Z","sha256":"ae68d3e8439ed9e2acdc0c9b7d06ca36927d4f00b2d44e7e8c02b26c057d7bd2","source_id":"us-cfr","stale":true,"prev":"us/10-cfr-35.14","next":"us/10-cfr-35.18"},"notice":"GroundRules: Original legal text. Not legal advice."}